SHILESH IYER: Open Payments
NPI 1841351277 · VALENCIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 41 payments from 11 companies in 2025. Trend: 2023 $837 · 2024 $793 · 2025 $653
Food & beverage: $653
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 23 | $167 |
| GENZYME CORPORATION | 4 | $133 |
| Lilly USA, LLC | 3 | $74 |
| ABBVIE INC. | 2 | $53 |
| Botanix SB Inc | 2 | $46 |
| UCB, Inc. | 1 | $43 |
| Arcutis Biotherapeutics, Inc. | 2 | $37 |
| Galderma Laboratories, L.P. | 1 | $29 |
| Incyte Corporation | 1 | $25 |
| LEO Pharma Inc. | 1 | $24 |
Products named: DUPIXENT, CIBINQO, LITFULO, EBGLYSS, SOFDRA, Bimzelx, Zoryve, DYSPORT.
Industry payments across CA — which companies pay providers there.
